Caraveo Gabriela, van Rossum Damian B, Patterson Randen L, Snyder Solomon H, Desiderio Stephen
Department of Molecular Biology and Genetics, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Science. 2006 Oct 6;314(5796):122-5. doi: 10.1126/science.1127815.
TFII-I is a transcription factor and a target of phosphorylation by Bruton's tyrosine kinase. In humans, deletions spanning the TFII-I locus are associated with a cognitive defect, the Williams-Beuren cognitive profile. We report an unanticipated role of TFII-I outside the nucleus as a negative regulator of agonist-induced calcium entry (ACE) that suppresses surface accumulation of TRPC3 (transient receptor potential C3) channels. Inhibition of ACE by TFII-I requires phosphotyrosine residues that engage the SH2 (Src-homology 2) domains of phospholipase C-g (PLC-g) and an interrupted, pleckstrin homology (PH)-like domain that binds the split PH domain of PLC-g. Our observations suggest a model in which TFII-I suppresses ACE by competing with TRPC3 for binding to PLC-g.
TFII-I是一种转录因子,也是布鲁顿酪氨酸激酶的磷酸化靶点。在人类中,跨越TFII-I基因座的缺失与一种认知缺陷——威廉姆斯-贝伦认知谱相关。我们报告了TFII-I在细胞核外作为激动剂诱导的钙内流(ACE)的负调节因子的意外作用,它可抑制瞬时受体电位C3(TRPC3)通道的表面积累。TFII-I对ACE的抑制作用需要磷酸酪氨酸残基,这些残基与磷脂酶C-γ(PLC-γ)的SH2(Src同源2)结构域结合,以及一个中断的、类似普列克底物蛋白同源(PH)的结构域,该结构域与PLC-γ的分裂PH结构域结合。我们的观察结果提示了一个模型,即TFII-I通过与TRPC3竞争结合PLC-γ来抑制ACE。